Skip to Content
Merck
  • Cytochrome P-450 and monooxygenase activity in hepatic microsomes from N-phenylimidazole-treated rats.

Cytochrome P-450 and monooxygenase activity in hepatic microsomes from N-phenylimidazole-treated rats.

Toxicology letters (1985-05-01)
M Murray, C F Wilkinson, K Hetnarski
ABSTRACT

Repeated administration of N-phenylimidazole (PI) to rats (3 daily doses of 200 mumol/kg/day) enhanced hepatic microsomal cytochrome P-450 levels (approx. 130%) and aminopyrine N-demethylase (APDM) and aniline p-hydroxylase (APH) activities (approx. 140%); aryl hydrocarbon (benzo[a]pyrene) hydroxylase (AHH) and 7-ethoxycoumarin O-deethylase (ECOD) activities were not enhanced over control values under similar conditions. Spectral studies with PI-induced microsomes indicated that although type II PI-binding characteristics were similar to those observed in controls, the 427 nm/455 nm absorbance ratio of the type III dihydrosafrole metabolite-cytochrome P-450 complex was lower than that in control microsomes. The results suggest that the inducing characteristics of PI bear some resemblance to those of phenobarbital (PB).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1-Phenylimidazole, 97%